ClinicalTrials.gg
Drug

Remimazolam tosylate clinical trials

Also written Remimazolam Tosilate.

A product of Remimazolam; its studies count on that page too.

studies test it
23
open now
3
in phase 3
6
first study started
2013

How each study uses remimazolam tosylate is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the remimazolam tosylate studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Remimazolam Tosylate
4
Remimazolam Tosilate for injection
2

Development codes

HR7056
1

Other names

Remimazolam Tosilate
15

Studies by the year they started

23 studies that test it; most in 2021 (5)

Studies that test remimazolam tosylate, by start year
YearStudies
20131
20142
20161
20171
20181
20191
20201
20215
20222
20233
20242
20252
20261

By phase

A phase 1/2 study counts in both.

Phase 1
3
Phase 2
6
Phase 3
6
Phase 4
4
No phase
6

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 15 · Other 8

Jiangsu HengRui Medicine Co., Ltd. (14) · RenJi Hospital (2) · The First Hospital of Hebei Medical University (1) · Tongji Hospital (1) · Sichuan Provincial People's Hospital (1) · Peking University People's Hospital (1) · Fujian Shengdi Pharmaceutical Co., Ltd. (1) · Shiyou Wei (1)

Related medicines

As reviewed, each with the page that says it.

Studies

Open first, then newest update. How each study uses remimazolam tosylate is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 23

See all 23 studies that test remimazolam tosylate →

Given beside what is tested · 2 — remimazolam tosylate is usual care or a partner of the new treatment

What changed recently

From the registry's own updates since Oct 18, 2026.

Codes

What other systems call remimazolam tosylate · ClinicalTrials.gg INT015875

  • UNII (FDA) 9J7J08A8LTREMIMAZOLAM TOSYLATEConfirmed FDA, Wikidata
  • Wikidata Q27272625remimazolam tosylateConfirmed FDA, Wikidata
  • NCI Thesaurus C179563Remimazolam TosylateOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.